All Cancer articles
See all articles with this subject.
-
Expert BriefingPatient Safety Watch: Some progress but blame culture still persists
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chair Jeremy Hunt
-
NewsDiagnostics performance slides despite NHSE hailing ‘record summer’
Performance on the NHS’s main diagnostic target has dropped back a year despite efforts to increase capacity and ramp up activity, figures published on Thursday show.
-
PodcastHSJ Podcast: What Ian Dodge learned about legislation
The HSJ Health Check podcast is tracking development of the government’s planned Health Bill. This week, we talk to Ian Dodge, who shaped several major pieces of NHS legislation as long-serving policy lead at NHS England and the Department of Health.
-
CommentLeague tables won’t save lives – transparency will
Mid Staffs showed the dangers of chasing targets. New NHS league tables risk repeating these mistakes, endangering patient safety
-
PodcastHSJ Podcast: Why the NHS is going private for cancer checks
This week we discuss an exclusive story about a major expansion of cancer testing centres that will see the private sector take on a bigger role delivering NHS services.
-
NewsExclusive: Dozens more private testing centres planned by government
The government and NHS England are gearing up to announce the opening of dozens more cancer testing centres – including a big expansion in those run outside the NHS, HSJ has learned.
-
NewsHospitals lose income as Gulf state slashes referrals
London private patient units have seen their income dented over the past year as Kuwait reduces the number of patients it refers abroad for treatment.
-
NewsKey target hit for sixth straight month
Ambulance services have met a key target for the sixth month running, for the first time since the pandemic.
-
CommentImprovements in cancer care are benefitting some more than others
England’s cancer plan must amplify patient voices, address inequalities and improve support, ensuring person-centred care across pathways from diagnosis to survivorship, says Olli Potter
-
HSJ InteractiveWATCH: Is precision medicine the future of modern cancer care?
Welcome to the first video in our series, created in collaboration with AstraZeneca for Cancer: Project Zero.
-
HSJ PartnersLung cancer diagnosis in England: Can we do better?
Discussions and reflections from the HSJ Cancer Forum Panel discussion, 12 March 2025
-
NewsEx-No 10 and NHSE advisers join same firm
One of the country’s leading decision-makers on cancer drugs and a former Downing Street health adviser have taken up new roles at a consultancy firm.
-
HSJ PartnersUnlocking innovation in cancer care: A call to action for system-level change (AstraZeneca sponsored)
At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from clinicians, digital leads, and operational decision-makers across multiple cancer pathways.
-
HSJ AwardsHSJ Digital Awards 2025: Improving Primary Care Through Digital
WINNER Suffolk and North East Essex Integrated Care Board: Using AI to Detect Skin Cancer Earlier and Transform Patient Experience in Primary Care
-
HSJ AwardsHSJ Digital Awards 2025: Empowering Patients Through Digital
WINNER The Newcastle upon Tyne Hospitals Foundation Trust: Empowering Teenage and Young Adults - a Co-Produced Resource Explaining Cancer Research, Enabling TYA’s to Make Informed Decisions Around Their Care
-
HSJ AwardsHSJ Digital Awards 2025: Driving Change Through Data and Analytics Award
WINNER East of England Cancer Alliance: Closing The Gap on Cancer Waits in the East of England
-
CommentThe patient voice is being silenced
Patients are being shut out of the NHS conversation, as lived experience and recovery support are increasingly ignored
-
HSJ PartnersCardiovascular health – the key to better cancer outcomes
Accord shares how cardiovascular risk impacts long-term patient outcomes in cancer care and how many survivors are at an increased risk of CVD due to the treatments themselves
-
HSJ PartnersTackling the systemic and economic burden of multiple myeloma in England
Multiple myeloma accounts for 15 per cent of all blood cancers and in recent years, its prevalence has risen sharply and is set to continue to increase by 67 per cent over the next 20 years.1,2
-
HSJ PartnersBringing equity and consistency to cancer care
Boehringer Ingelheim shares how it is addressing healthcare inequalities in cancer care, with a particular emphasis on treatment accessibility, genomic testing, and standardising the management of rare cancers.